May 8, 2018 / 11:28 AM / 6 months ago

BRIEF-Redhill Biopharma Posts Q1 Loss Of $0.05 Per Ordinary Share

May 8 (Reuters) - Redhill Biopharma Ltd:

* REDHILL BIOPHARMA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 REVENUE $2.4 MILLION

* REDHILL BIOPHARMA - DOES NOT HAVE PLANS TO RAISE ADDITIONAL CAPITAL AHEAD OF MAP US PHASE III STUDY TOP-LINE RESULTS WITH RHB-104 FOR CROHN'S DISEASE

* QTRLY LOSS PER ORDINARY SHARE $0.05

* CASH BALANCE AS OF MARCH 31, 2018 WAS $36.4 MILLION, COMPARED TO $46.2 MILLION AS OF DECEMBER 31, 2017 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below